Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria

Biomaterials

Volumn 33, Issue 34, 2012, Pages 8771-8781

  Cai, Xue ^a   Sezate, Steven A ^a   Seal, Sudipta ^c   McGinnis, James F ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Antioxidant; Gene expression; Longevity; Nanoceria; Retinal degeneration; Tubby mouse

Indexed keywords

ANTIOXIDANTS; DRUG THERAPY; EYE PROTECTION; GENES; MAMMALS; OPHTHALMOLOGY; VISION;

INTRAVITREAL INJECTION; LONGEVITY; MISLOCALIZATION; NANO-CERIA; RETINAL DEGENERATIONS; RETINAL STRUCTURE; THERAPEUTIC AGENTS; TUBBY MOUSE;

GENE EXPRESSION;

ANTIOXIDANT; CONE OPSIN; NANOCERIA; SCOTOPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETINA DEGENERATION; UPREGULATION;

MUS;

EID: 85027950910     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.030     Document Type: Article

References (61)

1. Kleyn P.W., Fan W., Kovats S.G., Lee J.J., Pulido J.C., Wu Y., et al. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 1996, 85:281-290.
2. Noben-Trauth K., Naggert J.K., North M.A., Nishina P.M. A candidate gene for the mouse mutation tubby. Nature 1996, 380:534-538.
3. Heckenlively J.R., Chang B., Erway L.C., Peng C., Hawes N.L., Hageman G.S., et al. Mouse model for Usher syndrome: linkage mapping suggests homology to Usher type I reported at human chromosome 11p15. Proc Natl Acad Sci U S A 1995, 92:11100-11104.
4. Ohlemiller K.K., Hughes R.M., Mosinger-Ogilvie J., Speck J.D., Grosof D.H., Silverman M.S. Cochlear and retinal degeneration in the tubby mouse. Neuroreport 1995, 6:845-849.
5. Kong L., Li F., Soleman C.E., Li S., Elias R.V., Zhou X., et al. Bright cyclic light accelerates photoreceptor cell degeneration in tubby mice. Neurobiol Dis 2006, 21:468-477.
6. Bode C., Wolfrum U. Caspase-3 inhibitor reduces apototic photoreceptor cell death during inherited retinal degeneration in tubby mice. Mol Vis 2003, 9:144-150.
7. Cantley L.C. Transcription. Translocating tubby. Science 2001, 292:2019-2021.
8. Ohia S.E., Opere C.A., Leday A.M. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res 2005, 579:22-36.
9. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000, 45:115-134.
10. Hollyfield J.G. Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture. Invest Ophthalmol Vis Sci 2010, 51:1275-1281.
11. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97:1634-1658.
12. Karakoti A., Singh S., Dowding J.M., Seal S., Self W.T. Redox-active radical scavenging nanomaterials. Chem Soc Rev 2010, 39:4422-4432.
13. Karakoti A.S., Monteriro-Riviere N.A., Aggarwal R., Davis J.P., Narayan R.J., Self W.T., et al. Nanoceria as antioxidant: synthesis and biomedical applications. JOM 2008, 60:33-37.
14. Singh S., Dosani T., Karakoti A.S., Kumar A., Seal S., Self W.T. A phosphate-dependent shift in redox state of cerium oxide nanoparticles and its effects on catalytic properties. Biomaterials 2011, 32:6745-6753.
15. Das M., Patil S., Bhargava N., Kang J.F., Riedel L.M., Seal S., et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28:1918-1925.
16. Alili L., Sack M., Karakoti A.S., Teuber S., Puschmann K., Hirst S.M., et al. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials 2011, 32:2918-2929.
17. Chen J., Patil S., Seal S., McGinnis J.F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006, 1:142-150.
18. Zhou X., Wong L.L., Karakoti A.S., Seal S., McGinnis J.F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS One 2011, 6:e16733.
19. Kong L., Cai X., Zhou X., Wong L.L., Karakoti A.S., Seal S., et al. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol Dis 2011, 42:514-523.
20. Edelhauser H.F., Rowe-Rendleman C.L., Robinson M.R., Dawson D.G., Chader G.J., Grossniklaus H.E., et al. Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci 2010, 51:5403-5420.
21. Cai X., Sezate S.A., McGinnis J.F. Neovascularization: ocular diseases, animal models and therapies. Adv Exp Med Biol 2012, 723:245-252.
22. Cai X., Nash Z., Conley S.M., Fliesler S.J., Cooper M.J., Naash M.I. A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles. PLoS One 2009, 4:e5290.
23. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
24. Dorrell M.I., Aguilar E., Jacobson R., Yanes O., Gariano R., Heckenlively J., et al. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J Clin Invest 2009, 119:611-623.
25. Farjo R., Skaggs J.S., Nagel B.A., Quiambao A.B., Nash Z.A., Fliesler S.J., et al. Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors. J Cell Biol 2006, 173:59-68.
26. Kong L., Tanito M., Huang Z., Li F., Zhou X., Zaharia A., et al. Delay of photoreceptor degeneration in tubby mouse by sulforaphane. J Neurochem 2007, 101:1041-1052.
27. Cohen J.I., Roychowdhury S., DiBello P.M., Jacobsen D.W., Nagy L.E. Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 2009, 49:1709-1717.
28. Gao X., Talalay P. Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc Natl Acad Sci U S A 2004, 101:10446-10451.
29. Kong L., Zhou X., Li F., Yodoi J., McGinnis J., Cao W. Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice. Neurobiol Dis 2010, 38:446-455.
30. Mandal M.N., Patlolla J.M., Zheng L., Agbaga M.P., Tran J.T., Wicker L., et al. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med 2009, 46:672-679.
31. Tanito M., Masutani H., Kim Y.C., Nishikawa M., Ohira A., Yodoi J. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Vis Sci 2005, 46:979-987.
32. Taylor R.C., Acquaah-Mensah G., Singhal M., Malhotra D., Biswal S. Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress. PLoS Comput Biol 2008, 4:e1000166.
33. Boesze-Battaglia K., Goldberg A.F. Photoreceptor renewal: a role for peripherin/rds. Int Rev Cytol 2002, 217:183-225.
34. Connell G., Bascom R., Molday L., Reid D., McInnes R.R., Molday R.S. Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse. Proc Natl Acad Sci U S A 1991, 88:723-726.
35. Molday R.S., Hicks D., Molday L. Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest Ophthalmol Vis Sci 1987, 28:50-61.
36. Bennett J. Commentary: an aye for eye gene therapy. Hum Gene Ther 2006, 17:177-179.
37. Ahuja-Jensen P., Johnsen-Soriano S., Ahuja S., Bosch-Morell F., Sancho-Tello M., Romero F.J., et al. Low glutathione peroxidase in rd1 mouse retina increases oxidative stress and proteases. Neuroreport 2007, 18:797-801.
38. Sandbach J.M., Coscun P.E., Grossniklaus H.E., Kokoszka J.E., Newman N.J., Wallace D.C. Ocular pathology in mitochondrial superoxide dismutase (Sod2)-deficient mice. Invest Ophthalmol Vis Sci 2001, 42:2173-2178.
39. Qi X., Lewin A.S., Sun L., Hauswirth W.W., Guy J. SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Ann Neurol 2004, 56:182-191.
40. Singh S., Kumar A., Karakoti A., Seal S., Self W.T. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol Biosyst 2010, 6:1813-1820.
41. Tarnuzzer R.W., Colon J., Patil S., Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 2005, 5:2573-2577.
42. Heckert E.G., Karakoti A.S., Seal S., Self W.T. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 2008, 29:2705-2709.
43. Korsvik C., Patil S., Seal S., Self W.T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun 2007, 1056-1058.
44. Pirmohamed T., Dowding J.M., Singh S., Wasserman B., Heckert E., Karakoti A.S., et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun 2010, 46:2736-2738.
45. Adamian M., Pawlyk B.S., Hong D.H., Berson E.L. Rod and cone opsin mislocalization in an autopsy eye from a carrier of X-linked retinitis pigmentosa with a Gly436Asp mutation in the RPGR gene. Am J Ophthalmol 2006, 142:515-518.
46. Concepcion F., Chen J. Q344ter mutation causes mislocalization of rhodopsin molecules that are catalytically active: a mouse model of Q344ter-induced retinal degeneration. PLoS One 2010, 5:e10904.
47. Gao J., Cheon K., Nusinowitz S., Liu Q., Bei D., Atkins K., et al. Progressive photoreceptor degeneration, outer segment dysplasia, and rhodopsin mislocalization in mice with targeted disruption of the retinitis pigmentosa-1 (Rp1) gene. Proc Natl Acad Sci U S A 2002, 99:5698-5703.
48. Lopes V.S., Jimeno D., Khanobdee K., Song X., Chen B., Nusinowitz S., et al. Dysfunction of heterotrimeric kinesin-2 in rod photoreceptor cells and the role of opsin mislocalization in rapid cell death. Mol Biol Cell 2010, 21:4076-4088.
49. Hagstrom S.A., Adamian M., Scimeca M., Pawlyk B.S., Yue G., Li T. A role for the Tubby-like protein 1 in rhodopsin transport. Invest Ophthalmol Vis Sci 2001, 42:1955-1962.
50. Ito Y., Shimazawa M., Inokuchi Y., Yamanaka H., Tsuruma K., Imamura K., et al. Involvement of endoplasmic reticulum stress on neuronal cell death in the lateral geniculate nucleus in the monkey glaucoma model. Eur J Neurosci 2011, 33:843-855.
51. Shimazawa M., Inokuchi Y., Ito Y., Murata H., Aihara M., Miura M., et al. Involvement of ER stress in retinal cell death. Mol Vis 2007, 13:578-587.
52. Salminen A., Kauppinen A., Hyttinen J.M., Toropainen E., Kaarniranta K. Endoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularization. Mol Med 2010, 16:535-542.
53. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., et al. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007, 318:944-949.
54. Tzekov R., Stein L., Kaushal S. Protein misfolding and retinal degeneration. Cold Spring Harb Perspect Biol 2011, 3:a007492.
55. Sato K., Nakazawa M., Takeuchi K., Mizukoshi S., Ishiguro S. S-opsin protein is incompletely modified during N-glycan processing in Rpe65(-/-) mice. Exp Eye Res 2010, 91:54-62.
56. Rong Y., Distelhorst C.W. Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Ann Rev Physiol 2008, 70:73-91.
57. Dong Y., Zhang M., Liang B., Xie Z., Zhao Z., Asfa S., et al. Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 2010, 121:792-803.
58. Yang J., Pawlyk B., Wen X.H., Adamian M., Soloviev M., Michaud N., et al. Mpp4 is required for proper localization of plasma membrane calcium ATPases and maintenance of calcium homeostasis at the rod photoreceptor synaptic terminals. Hum Mol Genet 2007, 16:1017-1029.
59. Bourges J.L., Bloquel C., Thomas A., Froussart F., Bochot A., Azan F., et al. Intraocular implants for extended drug delivery: therapeutic applications. Adv Drug Deliv Rev 2006, 58:1182-1202.
60. Cheng L., Hostetler K., Valiaeva N., Tammewar A., Freeman W.R., Beadle J., et al. Intravitreal crystalline drug delivery for intraocular proliferation diseases. Invest Ophthalmol Vis Sci 2010, 51:474-481.
61. Hirst S.M., Karakoti A.S., Tyler R.D., Sriranganathan N., Seal S., Reilly C.M. Anti-inflammatory properties of cerium oxide nanoparticles. Small 2009, 5:2848-2856.